Towards a Belgian consensus for prevention of perinatal group B streptococcal disease

P Melin1, G Verschraegen, L Mahieu

  • 1Belgian Reference Laboratory for Group B Streptococci, Medical Microbiology, University Hospital of Liege, Belgium. Pierrette.melin@chu.ulg.ac.be

Insights

A Belgian consensus meeting favored a universal screening-based approach for preventing neonatal sepsis and meningitis caused by group B Streptococcus (GBS). This strategy, using penicillin for prophylaxis, aims to reduce GBS disease in newborns.

Area of Science:

  • Perinatal infectious disease
  • Neonatal health
  • Public health policy

Background:

  • Group B Streptococcus (GBS) is a leading cause of neonatal sepsis and meningitis in Belgium.
  • No national guidelines existed for GBS prevention in Belgium prior to 2001.
  • A national consensus meeting was convened in 2001 to establish prevention strategies.

Purpose of the Study:

  • To achieve a Belgian consensus on the prevention of perinatal group B Streptococcus disease.
  • To review current practices and epidemiological data.
  • To debate and recommend optimal prevention strategies.

Main Methods:

  • A national symposium in November 2001 brought together experts in obstetrics, neonatology, microbiology, and infectious diseases.
  • Presentations covered GBS epidemiology, cost-effectiveness of prevention, and management strategies.
  • Interactive sessions included discussions on existing practices and voting on key prevention elements.

Main Results:

  • 94% of participants supported a screening-based approach for GBS prevention.
  • 94% advocated for penicillin as the preferred antimicrobial prophylaxis over ampicillin.
  • 79% favored integrated neonatal prophylaxis for high-risk infants.

Conclusions:

  • The consensus strongly favored a universal screening-based approach for perinatal GBS disease prevention.
  • Evidence from Belgian epidemiology and cost-effectiveness analyses supported this decision.
  • A working group was established to draft national Belgian recommendations for GBS prevention.
Abstract

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...